According to a recent research report titled “Next Generation Cancer Diagnostics Market (By Technology: Next-generation Sequencing, Lab-on-a-chip & Reverse Transcriptase-PCR, qPCR & Multiplexing, Protein Microarrays, DNA Microarrays; By Application: Biomarker Development, Proteomic Analysis, CTC Analysis, Epigenetic Analysis, Genetic Analysis; By Cancer Type: Lung Cancer, Colorectal Cancer, Breast Cancer, Cervical Cancer, Others; By Function) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global next generation cancer diagnostics market size is projected to touch around USD 32.9 billion by 2032 and growing at a CAGR of 8.02% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the next generation cancer diagnostics market.
Key Takeaways:
- By technology, next-generation sequencing accounted highest revenue share of around 37.1% in 2022.
- By application, the biomarker development segment has held the largest revenue share of around 40.8% in 2022.
- By application, the genetic analysis segment is expanding at a CAGR of 11.2% over the forecast period 2023 to 2032.
- By cancer type, breast cancer is expected to grow at a CAGR of 10.1% over the forecast period.
- By function, the therapeutic monitoring segment has dominated the market with a revenue share of 26% in 2022 whereas the prognostic diagnostics segment is expected to reach a CAGR of 10.2% during the forecast period.
- By region, North America accounted largest revenue share of 40.7% in 2022.
- The Asia Pacific region is poised to grow at a CAGR of 12.1% over the forecast period
The report primarily focuses on the volume and value of the next generation cancer diagnostics market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.
Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3246
The research also highlights significant progressions in both organic and inorganic growth strategies within the global next generation cancer diagnostics market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the next generation cancer diagnostics market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.
Report Scope of the Next Generation Cancer Diagnostics Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 16.42 Billion |
| Market Size by 2032 | USD 32.9 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.02% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Technology, By Application, By Cancer Type, and By Function |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Hydraulic Tools and Equipment Market Size to Record US$ 71.33 billion by 2032
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the next generation cancer diagnostics market.
Key Market Players:
- GE HealthCare
- Koninklijke Philips N.V.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- QIAGEN
- Agilent Technologies, Inc. (Dako)
- Abbott
- Thermo Fisher Scientific Inc.
- Janssen Pharmaceuticals, Inc.
Segments Covered in the Report:
By Technology
- Next-generation Sequencing
- Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
- qPCR & Multiplexing
- Protein Microarrays
- DNA Microarrays
By Application
- Biomarker Development
- Proteomic Analysis
- CTC Analysis
- Epigenetic Analysis
- Genetic Analysis
By Cancer Type
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Cervical Cancer
- Others
By Function
- Therapeutic Monitoring
- Prognostics
- Companion Diagnostics
- Cancer Screening
- Risk Analysis
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Table of Content:
Key Market Players:
- GE HealthCare
- Koninklijke Philips N.V.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- QIAGEN
- Agilent Technologies, Inc. (Dako)
- Abbott
- Thermo Fisher Scientific Inc.
- Janssen Pharmaceuticals, Inc.
Segments Covered in the Report:
(Note*: We offer reports based on sub-segments as well. Kindly, let us know if you are interested)
By Technology
- Next-generation Sequencing
- Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
- qPCR & Multiplexing
- Protein Microarrays
- DNA Microarrays
By Application
- Biomarker Development
- Proteomic Analysis
- CTC Analysis
- Epigenetic Analysis
- Genetic Analysis
By Cancer Type
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Cervical Cancer
- Others
By Function
- Therapeutic Monitoring
- Prognostics
- Companion Diagnostics
- Cancer Screening
- Risk Analysis
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Why should you invest in this report?
This report presents a compelling investment opportunity for those interested in the global next generation cancer diagnostics market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for next generation cancer diagnostics. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.
Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.
Some of the key questions answered in this report:
- What is the size of the overall Next generation cancer diagnostics market and its segments?
- What are the key segments and sub-segments in the market?
- What are the key drivers, restraints, opportunities and challenges of the Next generation cancer diagnostics market and how they are expected to impact the market?
- What are the attractive investment opportunities within the Next generation cancer diagnostics market?
- What is the Next generation cancer diagnostics market size at the regional and country-level?
- Who are the key market players and their key competitors?
- What are the strategies for growth adopted by the key players in Next generation cancer diagnostics market?
- What are the recent trends in Next generation cancer diagnostics market? (M&A, partnerships, new product developments, expansions)?
- What are the challenges to the Next generation cancer diagnostics market growth?
- What are the key market trends impacting the growth of Next generation cancer diagnostics market?
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
